Biotalys NV (XBRU:BTLS) Altman Z-Score: N/A (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XBRU:BTLS Biotalys NV XBRU:BTLS
30 GF Score
Price €2.48
! 1 Warning Sign
View Full Analysis

What is Biotalys NV Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Biotalys NV has a Altman Z-Score of N/A, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Biotalys NV's Altman Z-Score or its related term are showing as below:


Biotalys NV  (XBRU:BTLS) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Biotalys NV Altman Z-Score Related Terms


Biotalys NV Altman Z-Score Historical Data

* Premium members only.

The historical data trend for Biotalys NV's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotalys NV Altman Z-Score Chart

Biotalys NV Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z-Score
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Biotalys NV Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XBRU:BTLS vs CTVA, CF, MOS: Altman Z-Score Comparison

For the Agricultural Inputs subindustry, Biotalys NV's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotalys NV Altman Z-Score vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Biotalys NV's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Biotalys NV's Altman Z-Score falls into.


XBRU:BTLS
30GF Score
Biotalys NV XBRU:BTLS
Altman Z-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biotalys NV Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Biotalys NV's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.3373+1.4*-1.4248+3.3*-0.7931+0.6*14.7787+1.0*0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was €19.73 Mil.
Total Current Assets was €11.40 Mil.
Total Current Liabilities was €4.74 Mil.
Retained Earnings was €-28.11 Mil.
Pre-Tax Income was €-15.76 Mil.
Interest Expense was €-0.11 Mil.
Revenue was €0.00 Mil.
Market Cap (Today) was €112.70 Mil.
Total Liabilities was €7.63 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(11.397 - 4.742)/19.729
=0.3373

X2=Retained Earnings/Total Assets
=-28.109/19.729
=-1.4248

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-15.756 - -0.108)/19.729
=-0.7931

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=112.702/7.626
=14.7787

X5=Revenue/Total Assets
=0/19.729
=0

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Biotalys NV has a Altman Z-Score of N/A indicating it is in Distress Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Biotalys NV Business Description

Other Exchanges 86C:Germany
Address Buchtenstraat 11, Ghent, BEL, 9051
Biotalys NV is an Agricultural Technology (AgTech) company developing Precision Biocontrol solutions based on proteins for the protection of crops in both the pre and post harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Its pipeline EVOCA 1st Gen, EVOCA NG, BioFun-6, and BioFun-7. It operates in single segment.
30GF Score

Get the complete analysis for XBRU:BTLS

Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.48
Price